Lataa...
Diabetes and gout: efficacy and safety of febuxostat and allopurinol
Aim Assess influences of demographics and co-morbidities of gout patients with or without diabetes on safety and efficacy of urate-lowering agents. Methods Post-hoc analysis of 312 diabetic and 1957 non-diabetic gout patients [baseline serum urate levels (sUA) ≥8.0 mg/dl] enrolled in a 6-month rando...
Tallennettuna:
Päätekijät: | , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Blackwell Publishing Ltd
2013
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3902994/ https://ncbi.nlm.nih.gov/pubmed/23683134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12135 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|